News

News

MicroPort® Listed Among “China’s 500 Most Valuable Brands” List Again for 2021 -

Beijing, China—For the second time, MicroPort Scientific Corporation (...

CAPRI Clinical Investigation of ENO™/TEO™/OTO™ Pacing System by MicroPort® CRM Completes First Enrollment of Chinese Patients -

Zhejiang, China, 22 June 2021 — Recently, the “Clinical Investigation ...

Endovastec™ Joins ICARUS 2021 Symposium -

Recently, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (E...

Firehawk® Receives Registration Approval in Venezuela -

Caracas, Venezuela, 22 June 2021 — The Firehawk® Rapamycin Target Elut...

First Implantation of Endovastec Minos Stent Graft System Completed in Brazil -

Minos® Abdominal Aortic Stent-Graft and Delivery System (Minos® Stent ...

MicroPort CRM announces European launch of Alizea™ and Borea™ pacemakers with Bluetooth® connectivity and streamlined remote monitoring -

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm man...

MSC Organized “If Pacemakers Could Talk” in Nanchang -

Jiangxi, China, 21 June 2021 — Recently, MicroPort Soaring CRM (MSC),...

MicroPort® MedBot DFVision® 3D Electronic Laparoscope Approved for Marketing by NMPA -

On June 8, 2021, MicroPort MedBot (Shanghai) Co., Ltd. (‘MicroPort® Me...

MicroPort® EP IceMagic® Cardiac Cryoablation System Enters “Green Path” -

On June 8, the IceMagic® Cardiac Cryoablation System, developed by Sha...

MicroPort® Participates in OCC 2021 and Announces One-Year Results of Firesorb® Pivotal Study FUTURE-II -

Recently, Shanghai Microport Medical (Group) Co., Ltd (MicroPort®) rec...

Firehawk Liberty™ Receives Registration Approval in Colombia -

Recently, the Firehawk Liberty™ Rapamycin Target Eluting Coronary Sten...

MicroPort® EP Successfully Performs First Procedure in Belgium -

A team of electrophysiologists in Belgium have successfully completed ...

MicroPort® EP Attends the 9th All-Russian Congress of Arrhythmology -

Shanghai MicroPort® Electrophysiology MedTech Co., Ltd. (MicroPort® EP...

MicroPort® Orthopedics at the 13th Annual Congress of the Chinese Association of Orthopedic Surgeons (CAOS 2021) -

MicroPort® Orthopedics recently participated in the 13th Annual Congre...

MicroPort® Subsidiary EndoPhix® Performs World’s First Permanently Implanted Balloon Rotator Cuff Functional Reconstruction Surgery -

The first implantation of the Archimedes® Balloon Rotator Cuff Reconst...

Microport® announces the First Patients Enrolled in the European TARGET FIRST Clinical Trial of the Firehawk™ Coronary Stent -

TARGET FIRST is a prospective, multicenter, randomized, controlled cli...